<DOC>
	<DOCNO>NCT00078390</DOCNO>
	<brief_summary>A study measure safety effectiveness S-3304 give combination conventional chemo-radiation therapy patient locally advance non-small cell lung cancer .</brief_summary>
	<brief_title>Study S-3304 Patients With Locally Advanced Non-Small Cell Lung Cancer</brief_title>
	<detailed_description>A two part study evaluate safety efficacy S-3304 combination standard therapy patient locally advance non-small cell lung cancer . The first part study Phase I design evaluate maximum tolerate dose S-3304 give combination radiation paclitaxel/carboplatin chemotherapy appropriate evaluation . The second part study randomize Phase II design evaluate efficacy recommend S-3304 dose combination chemo-radiation .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>S 3304</mesh_term>
	<criteria>INCLUSION CRITERIA newly diagnose nonsmall cell lung cancer stage IIIA nonresectable stage IIIB without pleural effusion ECOG performance status 01 adequate organ function clinically indicate able receive conventional chemoradiation therapy EXCLUSION CRITERIA patient prior history cancer , basal cell carcinoma appropriate treatment , prior systemic chemotherapy treatment patient serious intercurrent illness include HIV/AIDS , contraindicate paclitaxel/carboplatin thoracic irradiation treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2004</verification_date>
	<keyword>Lung cancer</keyword>
	<keyword>Lung carcinoma</keyword>
	<keyword>Non small cell lung cancer</keyword>
	<keyword>Stage IIIA non small cell lung cancer</keyword>
	<keyword>Stage IIIB non small cell lung cancer</keyword>
	<keyword>NSCLC</keyword>
	<keyword>Stage III</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>radiation</keyword>
	<keyword>chemoradiation</keyword>
	<keyword>matrix metalloproteinases</keyword>
	<keyword>neovascularization</keyword>
	<keyword>antiangiogenesis</keyword>
	<keyword>type IV collagenase</keyword>
	<keyword>Unresectable locally advanced non-small cell lung cancer</keyword>
</DOC>